Atara Biotherapeutics

ATRA · NASDAQ

$9.16+$0.20 (+2.23%)TodayMarket closed ·
Prev close $8.96

Who owns ATRA

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 75.1% of ATRA’s shares.

  • EcoR1 Capital, LLC17.2%
  • Panacea Venture14.6%
  • Adiumentum Capital Fund I LP14.3%
  • Adage Capital Management, L.P.9.4%
  • Next 6 largest institutions19.5%
  • All other shareholders24.9%
Top institutional holders of ATRA
HolderShares% of shares
EcoR1 Capital, LLC1.55M17.23%
Panacea Venture1.32M14.64%
Adiumentum Capital Fund I LP1.28M14.26%
Adage Capital Management, L.P.850.00K9.43%
Point72 Asset Management, L.P.687.72K7.63%
Redmile Group, LLC441.70K4.90%
Vanguard Capital Management, LLC247.05K2.74%
Mackenzie Financial Corporation233.25K2.59%
Geode Capital Management, L.L.C.75.13K0.83%
BlackRock Institutional Trust Company, N.A.73.05K0.81%

Largest mutual fund holders

Top mutual fund holders of ATRA
HolderShares% of shares
Vanguard Total Stock Market Index Fund158.65K1.76%
Mackenzie US Quantitative Small Cap Fund89.73K1.00%
Vanguard Extended Market Index Fund82.76K0.92%
Mackenzie GQE US Small Cap Fund66.98K0.74%
Fidelity Extended Market Index Fund35.39K0.39%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $5.74M (2 trades) and sold $3.28M (4 trades) of ATRA on the open market.

Latest ATRA insider transactions
InsiderTypeSharesValue
Cherry Brian NBuy104.17K$999.99K
Nguyen AnhCoSale5.06K$40.88K
Redmile Group, LLCOption exercise55.39K—
Redmile Group, LLCOption exercise38.73K—
Redmile Group, LLCOption exercise101.09K—
Redmile Group, LLCTax withholding60—
Redmile Group, LLCOption exercise195.21K—
Cherry Brian NAward24.00K—
Ciongoli Gregory AustinAward12.00K—
Fust Matthew KAward12.00K—

Short interest

Settled Sep 30, 2026

Shares short
321.79K
Days to cover
8.11
% of shares outstanding
3.57%
Average daily volume
39.66K
Change since last report
−20.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.